Backpacks for CARs

Torque’s “backpacks” activate CAR T cells locally

Torque Therapeutics Inc. is making “backpacks” for immune cell therapies that release immune stimulatory molecules at particular doses and locations to boost the cells’ activity without risking systemic exposure. The technology could augment the success of CAR T’s against blood cancers and help overcome the immunosuppressive microenvironment that makes solid tumors so hard to treat.

President and co-founder Ulrik Nielsen told BioCentury that Torque’s platform -- dubbed Deep-Primed --

Read the full 686 word article

User Sign In